ClinicalTrials.gg
Active, not recruitingNCT07761962Updated Aug 13, 2026

Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversible Pulpitis

An interventional study of Diode laser full pulpotomy and Sodium hypochlorite pulpotomy in Irreversible Pulpitis (Toothache), sponsored by King Abdullah University Hospital. Active, not recruiting at 1 site in Jordan. Open to participants aged 10 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-13.

Sponsored by King Abdullah University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Oct 2025, registered Aug 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Randomized
Ages
10 Years to 60 Years
Sex
All
01

Study summary

This study compares two methods used during full pulpotomy, a treatment for teeth with deep tooth decay that has exposed the dental pulp.

In the first method, the dentist removes the affected pulp tissue using a high-speed dental bur and then controls the bleeding using a sodium hypochlorite solution.

In the second method, the dentist also removes the affected pulp tissue using a high-speed dental bur, but a diode laser is used to control the bleeding. The laser may provide additional disinfection and achieve bleeding control more quickly.

After treatment, participants will be monitored to assess their level of pain relief. They will also return for follow-up visits at 6 months and 12 months, when dental X-rays will be taken to evaluate the success of the treatment.

Read the detailed description

Vital pulp therapy (VPT) is a minimally invasive treatment that aims to preserve the vitality and function of the dental pulp after exposure caused by deep caries. Compared with root canal treatment, VPT preserves the remaining healthy pulp tissue, allowing the tooth to maintain its natural defense mechanisms and reparative capacity. Full pulpotomy has become an accepted treatment option for permanent teeth with carious pulp exposure when the radicular pulp is considered healthy and capable of healing. Clinical studies have demonstrated high success rates for full pulpotomy in appropriately selected cases.

Successful pulpotomy depends on adequate removal of the inflamed coronal pulp tissue, effective control of pulpal bleeding, reduction of bacterial contamination, and placement of a suitable biocompatible pulp-capping material. Conventionally, hemostasis is achieved using sodium hypochlorite following removal of the coronal pulp tissue with a high-speed bur. Although this technique has demonstrated favorable outcomes, alternative methods that may improve hemostasis and enhance tissue healing continue to be investigated.

Diode lasers have been increasingly used in dentistry for soft tissue procedures because of their ability to provide precise tissue interaction, coagulation, and effective hemostasis. In addition to controlling bleeding, diode lasers have antimicrobial properties and may promote wound healing through biostimulatory effects that support tissue repair and reparative dentin formation. These characteristics suggest that diode laser-assisted pulpotomy may offer clinical advantages over the conventional technique.

Despite the increasing use of diode lasers in dentistry, clinical evidence regarding their use in full pulpotomy of permanent teeth with carious pulp exposure remains limited. Most published studies have evaluated diode laser pulpotomy in primary teeth or animal models, and randomized clinical trials in permanent teeth are lacking.

This randomized clinical trial is designed to compare diode laser-assisted full pulpotomy with the conventional full pulpotomy technique in permanent teeth with carious pulp exposure. In both study groups, the coronal pulp tissue will be removed using a conventional high-speed bur. In the control group, hemostasis will be achieved using sodium hypochlorite. In the experimental group, a diode laser will be used to achieve hemostasis following pulp removal. The same pulp-capping material and definitive restoration protocol will be used in both groups to ensure that the method of achieving hemostasis is the primary variable under investigation.

Participants will be evaluated for postoperative pain following treatment. Clinical and radiographic outcomes will be assessed at 6 and 12 months to determine treatment success. The study aims to determine whether diode laser-assisted full pulpotomy provides clinical and radiographic outcomes comparable to or better than those of the conventional technique.

02

Conditions studied

  • Irreversible Pulpitis (Toothache)

Browse trials for

Keywords

  • Carious pulp exposure
  • Laser
  • Pulpotomy
03

In context

Toothache

142 studies on the registry are indexed under Toothache; 28 are open to participants now.

This study's planned enrollment of 70 is below the median of 84 across 123 interventional studies indexed under Toothache.

Browse Toothache studies →

Lead sponsor

King Abdullah University Hospital is the lead sponsor of 55 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

    • Non -contributory medical history (SAI, II).

      • Premolar or Molar permanent tooth
      • Age range 10-60 years
      • Deep caries extending>= 2/3 of dentin or exposing the pulp on the radiograph
      • The tooth should give positive response to cold sensibility testing
      • Clinical diagnosis of irreversible pulpitis based on the symptoms and results of cold testing.
      • The tooth is restorable, probing pocket depth and mobility are within normal limits
      • No signs of pulpal necrosis including sinus tract or swelling

Exclusion criteria

Exclusion Criteria:

  • Medically compromised patient.

    • Non-restorable tooth.
    • Signs of pulpal necrosis including sinus tract or swelling.
    • No enough bleeding after the pulpotomy procedure.
    • Inability to achieve hemostasis within 10 min after the pulpotomy.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Full pulpotomy using diode laser for hemostasis

    Diode laser used after the full pulpotomy to achieve hemostasis following cutting of the pulp tissue.

    Procedure: Diode laser full pulpotomy

  • Active comparator
    Full pulpotomy using sodium hypochlorite for hemostasis

    The use of sodium hypochlorite to achieve hemostasis after cutting the pulp tissue to th level of root canal orifices

    Procedure: Sodium hypochlorite pulpotomy

Interventions

  • ProcedureDiode laser full pulpotomy

    The use of diode laser to achieve hemostasis after cutting the coronal part of the pulp tissue which is present in the tooth crown, down to the level of the canal orifices.

  • ProcedureSodium hypochlorite pulpotomy

    The use of Sodium hypochlorite to achieve hemostasis after full pulpotomy

06

What researchers measure

Primary outcomes

  1. Postoperative pain after pulpotomy

    Postoperative pain will be assessed using an 11-point Numeric Rating Scale (NRS), where 0 indicates "no pain" and 10 indicates "the worst pain imaginable." Participants will record their pain intensity at the prespecified postoperative time points.

    Time frame: One week after treatment

Secondary outcomes

  1. Success of pulpotomy

    Clinical and radiographic success will be evaluated at the follow-up visits. Clinical success is defined as the absence of spontaneous pain, tenderness to percussion, swelling, sinus tract, pathological mobility, or other signs and symptoms indicating pulpal or periapical disease. Radiographic success is defined as the absence of periapical radiolucency, furcation involvement, external or internal root resorption, widening of the periodontal ligament space, or other radiographic evidence of treatment failure.

    Time frame: Six and 12 months after treatment

Other outcomes

  1. Tooth survival

    Tooth survival will be defined as the percentage of treated teeth remaining in the mouth and functioning without extraction during the follow-up period, regardless of the radiographic findings as far as the tooth is asymptomatic.

    Time frame: 12 months after treatment

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: Undecided — Individual participant data will not be shared because of institutional data-sharing policies and the need to protect participant confidentiality.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2025 (actual). Primary completion is estimated for Jun 2027, 20 months after the start.

Of 44 non-industry interventional studies with no phase under Toothache, half reached primary completion within 5 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 15. This study's planned 20 months is above that.

Counting every sponsor, half of 45 studies reached it within 5 months; a quarter within 3 and three quarters within 12.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2026
First posted
Aug 13, 2026
StartActual
Oct 23, 2025
Primary completionEst.
Jun 2027
CompletionEst.
Jun 2030
Last update
Aug 13, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07761962
Lead sponsor
King Abdullah University Hospital
Responsible party
Nessrin Taha (Professsor, Jordan University of Science and Technology) — Principal investigator
First posted
Aug 13, 2026
Start date
Oct 23, 2025
Primary completion
Jun 2027 (estimated)
Completion
Jun 2030 (estimated)
Last update
Aug 13, 2026

Study contacts

Nessrin Taha, PhD
study chair · Jordan University of Science and Technology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion